These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23713599)

  • 21. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
    Donnelly LE; Barnes PJ
    Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COPD pipeline XV.
    Gross N
    COPD; 2012 Apr; 9(2):203-4. PubMed ID: 22409315
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
    Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic obstructive pulmonary disease--traditional bronchodilatation and targeted anti-inflammatory therapy].
    Mróz RM; Skopiński T; Hołownia A; Chyczewska E; Braszko JJ
    Pneumonol Alergol Pol; 2011; 79(1):32-8. PubMed ID: 21190151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The COPD pipeline XIX.
    Gross N
    COPD; 2012 Dec; 9(6):649-50. PubMed ID: 23244170
    [No Abstract]   [Full Text] [Related]  

  • 27. [Novel therapeutics for COPD].
    Hoshino Y; Muro S; Mishima M
    Nihon Rinsho; 2011 Oct; 69(10):1826-30. PubMed ID: 22073581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The COPD pipeline XVIII.
    Gross NJ
    COPD; 2012 Aug; 9(5):571-3. PubMed ID: 22946846
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging anti-inflammatory strategies for COPD.
    Cazzola M; Page CP; Calzetta L; Matera MG
    Eur Respir J; 2012 Sep; 40(3):724-41. PubMed ID: 22496331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Statins in COPD--theoretical reflections].
    Hannink JD; Heijdra YF
    Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
    Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
    Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The COPD Pipeline XXI.
    Gross N
    COPD; 2013 Apr; 10(2):266-8. PubMed ID: 23514258
    [No Abstract]   [Full Text] [Related]  

  • 33. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease.
    Deng X; Zhang Z; Gu W; Li Y; Liu M
    Exp Lung Res; 2012 Aug; 38(6):295-301. PubMed ID: 22646473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
    Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
    Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological treatment in asthma and COPD.
    Hoshino T; Toda R; Aizawa H
    Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of anti-inflammatory treatment with benacort in exacerbations of chronic obstructive lung disease].
    Kolesnikov VV; Korol'chuk IS
    Ter Arkh; 2003; 75(1):55-8. PubMed ID: 12652959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical pneumoplasty, surgical resection, or lung transplant.
    Cordova FC
    Med Clin North Am; 2012 Jul; 96(4):827-47. PubMed ID: 22793947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety study of infliximab in moderate-to-severe chronic obstructive pulmonary disease.
    Rennard SI; Flavin SK; Agarwal PK; Lo KH; Barnathan ES
    Respir Med; 2013 Mar; 107(3):424-32. PubMed ID: 23246078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.